Synolo Therapeutics

Synolo Therapeutics is developing a pipeline of multi-specific biologics with unique functionalities for treatment of cancer and autoimmune disease. These novel therapies are designed to precisely target cancer or other detrimental cells while minimizing off-target effects, offering the potential for more effective and less toxic treatments.

Synolo Therapeutics is developing a pipeline of multi-specific biologics with unique functionalities for treatment of cancer and autoimmune disease. These novel therapies are designed to precisely target cancer or other detrimental cells while minimizing off-target effects, offering the potential for more effective and less toxic treatments.